Tumor growth and progression require molecular interactions between malignant and host cells. In recent years, extracellular vesicles (EVs) emerged as an important pillar of such interactions, carrying molecular information from their donor cells to distant recipient cells. Thereby, the phenotype and function of the recipient cells are altered, which may facilitate tumor immune escape and tumor metastasis to other organs through the formation of pre-metastatic niches.
View Article and Find Full Text PDFHydrogen sulfide (HS) as a critical messenger molecule plays vital roles in regular cell function. However, abnormal levels of HS, especially mitochondrial HS, are directly correlated with the formation of pathological states including neurodegenerative diseases, cardiovascular disorders, and cancer. Thus, monitoring fluxes of mitochondrial HS concentrations both and with high selectivity and sensitivity is crucial.
View Article and Find Full Text PDFA resorufin-based dual-locked fluorescent probe (RHT) was introduced to image melanoma cells selectively. RHT was shown to function as an AND molecular logic gate as it emitted a signal only in the presence of both hydrogen sulfide (HS) and tyrosinase (Tyr), which are known to be overexpressed in melanoma cells. cell culture studies revealed that RHT can be activated with endogenous HS and Tyr and allows selective imaging of B16-F10 cancer cells under confocal microscopy.
View Article and Find Full Text PDFButyrylcholinesterase (BChE), one of the critical human cholinesterases, plays crucial roles in numerous physiological and pathological processes. Accordingly, it is a striking and at the same time challenging target for bioimaging studies. Herein, we developed the first ever example of a 1,2-dixoetane-based chemiluminescent probe (BCC) for monitoring BChE activity in native biological contexts such as living cells and animals.
View Article and Find Full Text PDFStroke is the second highest reason of death in the world and the leading cause of disability. The ischemic stroke makes up the majority of stroke cases that occur due to the blockage of blood vessels. Therapeutic applications for ischemic stroke include thrombolytic treatments that are in limited usage and only applicable to less than 10% of the total stroke patients, but there are promising new approaches.
View Article and Find Full Text PDF